STOCKWATCH
·
Pharmaceuticals
Business Update1 Apr 2024, 02:48 pm

Venus Remedies Receives Rs. 2.50 crores as Remaining Incentive under PLI Scheme

AI Summary

Venus Remedies Ltd has announced the receipt of Rs. 2.50 crores as the remaining part of its first incentive under the Production Linked Incentive (PLI) scheme. With this, the company has now received 100% of the incentive of Rs. 10.00 crores for the financial year 2022-23.

Key Highlights

  • Venus Remedies receives Rs. 2.50 crores as remaining incentive under PLI scheme
  • The company has now received 100% of the incentive of Rs. 10.00 crores for FY 2022-23
VENUSREM
Pharmaceuticals
VENUS REMEDIES LTD.

Price Impact